DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 132 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,117,000 | -56.4% | 106,493 | -39.4% | 0.00% | -50.0% |
| Q2 2016 | $2,563,000 | +16.7% | 175,729 | +53.9% | 0.01% | +20.0% |
| Q1 2016 | $2,196,000 | -18.7% | 114,156 | +2.1% | 0.01% | -16.7% |
| Q4 2015 | $2,701,000 | -3.4% | 111,765 | -1.9% | 0.01% | 0.0% |
| Q3 2015 | $2,797,000 | +7.8% | 113,957 | +2.9% | 0.01% | +20.0% |
| Q2 2015 | $2,594,000 | -80.8% | 110,736 | -81.6% | 0.01% | -81.5% |
| Q1 2015 | $13,527,000 | -43.8% | 603,072 | -57.8% | 0.03% | -44.9% |
| Q4 2014 | $24,077,000 | – | 1,428,092 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |